greeksoup/ stock research

Sabra Health Care REIT (SBRA) FY2024 results: revenue $703 million, up 8.6% on the year

Sabra Health Care REIT, Inc. (SBRA) reported revenue of $703 million for fiscal 2024, the year ended 31 December 2024, up 8.6% on the year before. Net income was $127 million, up 821.1%, and diluted earnings per share $0.54. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2025.

Revenue
$703 million
+8.6% on the year
FY2017FY2024
Operating margin
n/a
FY2017FY2024
Net income
$127 million
+821.1% on the year
FY2017FY2024
Diluted EPS
$0.54
+800.0% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue703648625+8.6%
Interest expense115113105+2.0%
Pre-tax income12818.721.7+586.8%
Income tax1.02.01.2-49.8%
Effective tax rate0.8%10.7%5.7%
Net income12713.8-77.6+821.1%
Net margin18.0%2.1%-12.4%
Diluted EPS$0.54$0.06-$0.34+800.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow311301316+3.3%
Cash from investing-109103-216
Cash from financing-182-410-162
Depreciation and amortisation170183188-7.4%
Share-based compensation9.07.97.5+13.5%
Dividends paid280277277+1.0%
Dividend per share$1.20$1.20$1.200.0%
Diluted shares, weighted236m233m231m+1.4%
Shares outstanding at period end238m231m231m+2.7%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity2,7412,8033,056-2.2%
Non-controlling interest0.0n/an/a
Debt2,4182,4142,507+0.1%
Other liabilities145170185-14.6%
Total liabilities and equity5,3045,3865,748-1.5%
Intangible assets27.530.940.1-11.1%
Cash and equivalents60.541.349.3+46.5%
Other assets5,2165,3145,658-1.8%
Total assets5,3045,3865,748-1.5%

10-K for the year ended 31 December 2024, filed 19 February 2025: the filing.